The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Open accessAbstract
Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed world. Evidence increasingly shows that these conditions are interlinked through common risk factors, coincident in an ageing population, and are connected biologically through some deleterious effects of anticancer treatment on CV health. Anticancer therapies can cause a wide spectrum of short- and long-term cardiotoxic effects. An explosion of novel cancer therapies has revolutionised this field and dramatically altered cancer prognosis. Nevertheless, these new therapies have introduced unexpected CV complications beyond heart failure. Common CV toxicities related to cancer therapy are defined, along with suggested strategies for prevention, detection and treatment. This ESMO consensus article proposes to define CV toxicities related to cancer or its therapies and provide guidance regarding prevention, screening, monitoring and treatment of CV toxicity. The majority of anticancer therapies are associated with some CV toxicity, ranging from asymptomatic and transient to more clinically significant and long-lasting cardiac events. It is critical however, that concerns about potential CV damage resulting from anticancer therapies should be weighed against the potential benefits of cancer therapy, including benefits in overall survival. CV disease in patients with cancer is complex and treatment needs to be individualised. The scope of cardio-oncology is wide and includes prevention, detection, monitoring and treatment of CV toxicity related to cancer therapy, and also ensuring the safe development of future novel cancer treatments that minimise the impact on CV health. It is anticipated that the management strategies discussed herein will be suitable for the majority of patients. Nonetheless, the clinical judgment of physicians remains extremely important; hence, when using these best clinical practices to inform treatment options and decisions, practitioners should also consider the individual circumstances of their patients on a case-by-case basis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to the cumulative cisplatin dose, peak drug exposure, young age at treatment, co-administration of other ototoxic drugs and others are well-defined risk factors for more severe auditory damage 167,168,169 .”
From Osteosarcoma (2022) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
Self-citation2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citationSlamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citationStone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Cited by
Sorted by citations
Items 901–999 of 999
Faithfull, S., & Greenfield, D. (2025) · Cancer Nursing Practice · doi:10.7748/cnp.2025.e1877
Chemotherapy-Associated Cardiotoxicity: A Silent Threat Evidenced in a Retrospective Cohort Study
Rossi, F. A. M., Cárdenas-Corredor, S., Osuna, L. F. S., Kunze, D. A. G., León-León, P., Guanopatin, D. A. S., Nates, V. M., Puente‐Maestu, L., Jaramillo, P. L. S., & Martinez, A. J. R. (2025) · Cureus · doi:10.7759/cureus.78905
SATO, T. A., Dai, Z., Hashimoto, J., Ohde, S., Komiyama, N., Inomata, T., & Yamauchi, T. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319342
Cardiovascular Risk Assessment in Prostate Cancer: The Role of Coronary Artery Calcium Scoring
Rosenbech, K. E., Saeid, A., Agarwal, M. A., & Mayntz, S. P. (2025) · Cardiology · doi:10.1159/000544911
Pfister, K., Schäffler, H., Huesmann, S., Fink, A., Rack, B. K., Janni, W., & Heublein, S. (2025) · Die Gynäkologie · doi:10.1007/s00129-025-05362-x
Zhu, L., Liang, F., Li, F., & Wang, J. (2025) · Heart and Mind · doi:10.4103/hm.hm-d-24-00137
Steroid-resistant immune checkpoint inhibitor-associated myocarditis: a case report
He, X., Zhang, Y., Wang, Y., Chen, H., Liu, Y., & Cheng, L. (2025) · Clinical Cancer Bulletin · doi:10.1007/s44272-025-00033-3
MicroRNA biomarkers in the diagnosis of oncological cardiotoxicity
Kušnierová, P., Švagera, Z., Michnová, O., Hlozankova, M., Kosztyu, P., Chalupová, L., Dvořáková, B., Seidlová, V., Petr, R., Knot, J., et al. (2023) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2023.004
The association between surgery type and heart-specific mortality in male breast cancer
Şanlı, A. N. (2025) · Journal of Surgery and Medicine · doi:10.28982/josam.7844
Integrated multiomics & systems medicine approach in precision cardio-oncology
Agwuegbo, C. C., Bolaji, O., Rickards, J., Mbagwu, G. N., & Brown, S.-A. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29829-5.00024-4
Medical society synergies in cardio-oncology
Volgman, A. S., Beavers, C. J., Thakker, J., Rickards, J., & Zaha, V. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29829-5.00006-2
Evaluating the Necessity and Impact of Cardiac Imaging on Breast Cancer Care in Northwestern Ontario
Shortreed, H., Clark, M., Abdel-Qadir, H. M., Siddiqui, R., & Aseyev, O. (2025) · Cancers · doi:10.3390/cancers17121909
Garzón-Dangond, J. M., Ardila, M. F. G., Tellez‐Garcia, E., Daryanani, A. E., Peethambaram, P. P., Thicke, L., Stan, D. L., & Villarraga, H. R. (2025) · Cardio-Oncology · doi:10.1186/s40959-025-00350-5
Onny, R., Harjianti, T., Tandean, P., Bakri, S., Sanusi, H. D., & Zainuddin, A. A. (2025) · Ukrainian journal of cardiovascular surgery · doi:10.63181/ujcvs.2025.33(2).75-80
Okura, Y., Tanabe, N., Kashimura, T., Ishiguro, T., Ikarashi, M., Kanbayashi, C., Kaneko, K., Sakata, E., Tsuchida, K., Kikuchi, A., et al. (2025) · Circulation Reports · doi:10.1253/circrep.cr-24-0185
Ibe, F. O., Ugwu, C. J., Eidbo, S., Ossai, J., Ugoala, O. S., Otabor, E., Nriagu, V. C., Ebubechukwu, U. J., Adike, O., & Irhoboudu, A. (2025) · medRxiv · doi:10.1101/2025.06.29.25330534
Gireesh, G. R., & Chacko, L. K. (2025) · Journal of Health and Allied Sciences NU · doi:10.25259/jhs-2024-5-23-r3-(1394
Cardiotoxicity of antitumor therapy in children. Literature review
Turkiya, L. R. (2025) · Medical alphabet · doi:10.33667/2078-5631-2025-14-20-25
Shotton, R., Campbell, A. E., Baričević-Jones, I., Reed, R., Kelsall, J., Williams, J., Mellor, H. R., Unwin, R. D., & Linton, K. (2026) · Cardio-Oncology · doi:10.1186/s40959-026-00484-0
Smith, S. J., Gibson, C., Moorin, R. E., Newton, J. C., & Maxwell‐Smith, C. (2026) · Breast Cancer Research · doi:10.1186/s13058-026-02264-1
Cardiovascular toxicity risks in treating EGFR -mutated lung cancer
Zhang, J., Liu, X., & Xu, Y. J. (2025) · BMJ · doi:10.1136/bmj.r1834
Synergistic Effect of Risk Factors and Cardiotoxic Cancer Therapies
Wong, J. H., Soh, C. H., Smith, J., Huynh, Q. L., Kosmala, W., & Marwick, T. H. (2025) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2025.08.007
Yazid, M., Lnu, M., Koesnoe, S., Rinaldi, I., Winston, K., & Putra, D. (2025) · Cureus · doi:10.7759/cureus.91632
Doxorubicin Induced Mitochondrial Dysfunction and Cardiotoxicity
Bhullar, S. K., Thingnam, R., Rabinovich-Nikitin, I., & Kirshenbaum, L. A. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_17
Lima, M. L. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_33
Jóźwik−Plebanek, K., Saracyn, M., Kołodziej, M., Mądra, W., Durma, A. D., Dziuk, M., Balcerska, Z., Janiak, K., Gniadek-Olejniczak, K. A., & Kamiński, G. (2025) · Cancers · doi:10.3390/cancers17193219
Chemotherapy-Induced Cardiotoxicity in Cancer Treatment: Mechanisms and Its Prevention
Osataphan, N., Leemasawat, K., Phrommintikul, A., Chattipakorn, S. C., & Chattipakorn, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00775-9_344
Ma, Y., Guan, L., Li, X., Zhang, J., Li, X.-M., & Mu, Y. (2025) · Journal of Clinical Ultrasound · doi:10.1002/jcu.70108
da Conceição, V. M., & Dantas, R. A. S. (2025) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2026v72n1.5420
Ghorayeb, I. K., Silveira, A. M., Silva, G. M. R. S., Navarro, V. S., Silva, V. H. T. R. D., Silva, G. C., & Polo, A. L. (2025) · LUMEN ET VIRTUS · doi:10.56238/levv16n53-094
Rahim, F., Gozin, S., Karim, S. H., Qumar, A. B., Doostali, K., & Issenova, B. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003224
Hafez, M. M., Yunis, M., Darwish, A., Ahmed, E. O., Fathy, K., & Hussein, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-91777-4
Stevenson, M., Park, S., Hartshorne, T., Mendoza, Z., Nguyen, V. Q., Wong, L., Chiles, C. D., & Widmer, R. J. (2025) · Cardiac Research · doi:10.1097/re9.0000000000000003
Shui, W., Wu, X., Liu, H., Li, Z., & Zheng, G. (2025) · Human Genomics · doi:10.1186/s40246-025-00888-6
Cardiovascular Risk Factors in Chronic Lymphocytic Leukemia: Early Diagnosis and Prevention Options
Tkachenko, L. A., Pristrom, A. M., Мицура, В. М., & Tolkacheva, Y. V. (2025) · Medical and Biological Problems of Life Activity · doi:10.58708/2074-2088.2025-4(36)-22-29
Rahman, H. A. U., Iqbal, N., Fahim, M. A. A., Salman, F., Ahmed, S. H., Asim, O., Mansoor, T., Farooq, M. Z., & Asghar, M. S. (2025) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2025.100699
Bouwer, N. I., Liesting, C., Kofflard, M. J. M., Brugts, J. J., Kock, M. C. J. M., Kitzen, J. J. E. M., Levin, M.-D., & Boersma, E. (2021) · Figshare · doi:10.6084/m9.figshare.16969322
Kamphuis, J. A. M., Linschoten, M., Cramer, M. J., Doevendans, P. A., Asselbergs, F. W., & Teske, A. J. (2020) · Figshare · doi:10.6084/m9.figshare.13088097
Li, Y., Ong, W. S., Shwe, M. T. T., Yit, N. L. F., Quek, S. Z. H., Pang, E. P. P., Looi, W. S., Nei, W. L., Wang, M. L. C., Chua, M. L. K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19359526
Venkatesh, P., Yan, K. L., Bravo-Jaimes, K., Yang, E. H., & Lluri, G. (2022) · Figshare · doi:10.6084/m9.figshare.21622538
Hedayati, E., Papakonstantinou, A., Månsson‐Broberg, A., Bergh, J. C. S., Hűbbert, L., & Altena, R. (2020) · Figshare · doi:10.6084/m9.figshare.12904764
Kulyova, A. A., Kulyova, S. A., Хабарова, Р. И., Senchurov, E. M., Михайлова, Е. А., Borokshinova, K. M., Ignatova, V. S., Prosekina, E. A., & Вершинина, Т. Л. (2025) · Podderživaûŝaâ terapiâ v onkologii. · doi:10.17650/3034-2473-2025-2-3-76-84
Physiological Changes during Malignancy and its Anesthetic Considerations
Chen, S.-Y. E., & Zhou, C. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898813727125010005
Khokhar, M. M., Mohammad, S., Javeid, A., Rathi, D., Salman, M. F., Altaf, S., Ahmad, H. F., Hashir, M., Elshabrawi, M. N., Akoum, A., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-8232781/v1
CARDIOTOXICITY OF CHEMOTHERAPY: THE ROLE OF BIOMARKERS AND IMAGING
Івчина, Н. (2025) · Clinical and Preventive Medicine · doi:10.31612/2616-4868.8.2025.20
Nachsorge Mammakarzinom – Was ist Standard – und warum nicht mehr?
Kaschner, K., Baur, M., Claussen, A., Hielbig, A., Tauber, N., Rody, A., & Banys‐Paluchowski, M. (2026) · Die Gynäkologie · doi:10.1007/s00129-025-05460-w
Aminian, F., & Becher, H. H. (2026) · Springer eBooks · doi:10.1007/978-3-032-02269-1_11
The significance of long-term patients monitoring after anthracycline administration
Popović, J., Dukić, Đ., Vasić, D., & Ivanović, B. (2023) · Srce i krvni sudovi · doi:10.5937/siks2302046p
Julka-Anderson, N., Bryce, R., Nicola, S., Davis, J., & Taylor, C. (2026) · Cancer Nursing Practice · doi:10.7748/cnp.2026.e1904
He, Z., Luo, Z., Dai, P., Wang, X., & Yang, J. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105153
The emerging role of echocardiography-based techniques in cardio-onco-hematology
Zhang, Y., Xie, M., Wang, J., & Zhang, B. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1696096
Cardio-Oncology: At the Nexus of Two 21st Century Epidemics
Radia, U. K., Ahluwalia, V., & Rosen, S. D. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm50393
Kumari, R., Harshavardhan, N., Jain, S., Hussain, N., & Kashyap, N. K. (2026) · Cureus · doi:10.7759/cureus.103139
Stratification system for pharmaceutical care in cancer patients: Chinese expert consensus
Chen, Y., Ma, X., Lin, M., Hu, Z., Zhou, J., Qiu, Y., Liu, Z., Du, S., Shi, L., Han, L., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1707229
Yusupova, A. M., Курбановна, Ш. Е., Poltavskaya, M. G., Khamzatkhanova, A. K., Karaganov, K. S., Novikova, A. I., Shvyakova, Y. O., Galkin, V. N., & Andreev, D. A. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-6734
Tao, S., Yu, L., Zhang, L., Li, J., Wu, J., & Tan, Y. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s572304
Kim, S., Han, K. D., Jung, J., Song, Y.-M., Park, J.-H., Cho, J. H., & Shin, D. W. (2025) · British journal of surgery · doi:10.1093/bjs/znaf264
Cardiotoxicity associated with anticancer therapies for gynecological tumors
Yang, L., Liao, J., Li, J., & 王赞宏 (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1779990
Kemp, E., Lawn, S., Michelle, M., Selvanayagam, J. B., Kaambwa, B., Reed, R. L., Hunt, L., Woodman, R. J., Ullah, S., Morton, E. B., et al. (2026) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.10.012
Nardin, S., Vezzoli, F., Cognolato, G., Mollace, R., Pollone, B. R., Biello, F., Cao, D., Tagliamento, M., Sarocchi, M., Pagnesi, M., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1790897
Ali, A., Clasen, S. C., Blaes, A. H., Casselli, S., Deswal, A., Demeter, S. H., Durm, G. A., Fadol, A. P., Ferrajoli, A., Fradley, M. G., et al. (2026) · Cancer Medicine · doi:10.1002/cam4.71682
Self-citationDoxorubicin-induced cardiotoxicity: mechanisms, surveillance, and prevention strategies
Zheng, H. (2026) · Cardiology Plus · doi:10.1097/cp9.0000000000000156
Cardiology Perspective: Approaches to Multimodality Quantitative Imaging in Cardio-Oncology Patients
Epstein, S. F., & Chen, M. H. (2026) · Springer eBooks · doi:10.1007/978-3-032-14103-3_13
Netsanet, A., Daud, A., & Florido, R. (2026) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-026-01139-0
Tsunoda, A., Mizuno, T., Nakamori, S., Ichikawa, M., Tono, Y., Saito, K., & Tawara, I. (2026) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s596107
Liu, W.-H., Cheng, Y.-J., Kang, J., Chen, J., An, Z.-J., Li, T.-H., Tan, N., Zhong, W., Wu, Y.-L., & Jiang, L. (2026) · Lung Cancer · doi:10.1016/j.lungcan.2026.109413
Nabhan, E. M., Vana, A.-P., Khouri, R., Nehme, E. N., & Poulos, N. (2026) · Cureus · doi:10.7759/cureus.107433
Zhang, Y., & Tian, Y. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1818278
Basuoni, A., Salman, B. M., Al-Baimani, K. S., Farsi, S. A., Dawelbeit, W., Riyami, M. B. A., Makhlouf, M. A., Qarshoubi, I. A., Al-Riyami, A. B., & Rawahi, M. N. A. (2026) · Cardio-Oncology · doi:10.1186/s40959-026-00492-0
Nussbaum, A. C. A. S., Antonini, M., Mattar, A. P. L., Bacal, F., & Real, J. M. (2026) · Cardio-Oncology · doi:10.1186/s40959-026-00490-2 · Cited by 1
Cardio-oncology, from Guidelines to Practice: Filling the Gap – an Eastern European Viewpoint
Ivănescu, A. C., Dulf, P. L., Dulf, D. V., & Dan, G. (2026) · European Cardiology Review · doi:10.15420/ecr.2025.102
Peut-on prédire, détecter et prévenir la cardiotoxicité des médicaments anticancéreux ?
Mirabel, M. (2026) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2025.05.019
Homeniuk, A., Karthikeyan, G., & Atrash, A. (2026) · Cureus · doi:10.7759/cureus.108414
Karputs, I. A. (2024) · Vestnik of Vitebsk State Medical University · doi:10.22263/2312-4156.2024.4.37
Zsilavecz, V. W., Genger, M., Zirngast, B., & Andreas, M. (2026) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytag346
From data to decision: a clinical pipeline for wearable AI in early cardiotoxicity detection
Zhou, Z., & Wang, J. (2026) · Cardio-Oncology · doi:10.1186/s40959-026-00506-x · Cited by 1
Kardioonkologie: Kardiotoxizität onkologischer Therapien erhöht Mortalität deutlich
Berliner, D., GAUSEPOHL, T., Wang, D., & Bauersachs, J. K. (2026) · Deutsches Ärzteblatt · doi:10.3238/perskardio.2026.05.29.01
The Current State Of Knowledge On The Management Of Ischemic Heart Disease In Patients With Cancer
Barkhudaryan, A., Левонович, Ч. А., & Tunyan, L. G. (2026) · THE NEW ARMENIAN MEDICAL JOURNAL · doi:10.56936/18290825-2026.20v.1-20
Gao, J., Fukasawa, T., Yamada, S., Takeuchi, M., Yamaguchi, F., Fan, D., & Kawakami, K. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10833-5
Abusanad, A. M., Iskanderani, O. F., Ujaimi, R. K., & Al‐Hajeili, M. (2025) · Saudi Journal of Internal Medicine · doi:10.4103/sjim.sjim_7_25
Dent, S., Nadler, M. B., Blaes, A., Iqbal, A., Ayettey, H. N. G., Alvarez-Cardona, J. A., Chan, A., Koh, E., Mascuñano, R. C., George, M., et al. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10741-8
Self-citationA Comprehensive Echocardiographic Assessment of Patients With Chronic Myeloid Leukemia on Dasatinib
Chen, C., Appadurai, V., Hernandez, M. P., Altman, J., & Akhter, N. (2026) · Echocardiography · doi:10.1111/echo.70517
Cardiac Computed Tomography in Cardio-oncology
Ferencik, M., & Lopez-Mattei, J. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10618-7.00018-1
Raval, R., Acharya, S., Hejmadi, S., Prakashkar, N., Kansara, A. L., Elmoursy, A., & Patel, Y. (2026) · Cureus · doi:10.7759/cureus.109966
Agrawal, S. P., Lussier, A., Patel, D. S., Thukral, J., Gopu, S. S., Shah, R. K., Patel, H., Frishman, W. H., & Aronow, W. S. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001334
Pallarés‐Carratalá, V., Justel-Pérez, J. P., Cinza‐Sanjurjo, S., Lopez-Fernandez, T., Turégano-Yedro, M., García, A. R., Kwifatie, A. K.-N., Peña-López, J., Zamora-Auñón, P., Higuera, O., et al. (2026) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2026.102780
Themelidi, V., Maria, V., Varvarelis, O., Ιωακείμ, Κ., Kampouroglou, E., & Tsekoura, D. (2026) · Global Journal of Cancer Therapy · doi:10.17352/2581-5407.000056
Fang, H., Guo, B., Sun, Y., Jin, W., & Wang, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1845366
Preoperative cardiovascular evaluation in patients with cancer
Zehner, C., Beinart, N., Kim, J. H., Carrion, A. M. R., Paniagua-Bojorges, A., López-Moreno, S., Casso-Chapa, B., Ostos-Mendoza, K. C., Samanthapudi, V. S., Lee, J., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1780281
Fan, C., Fan, C., Liu, L., Wen, M., Li, C., Geng, Y., Ren, W., & Zhang, L. L. (2026) · Cancer Medicine · doi:10.1002/cam4.71965
González, V., Martínez, M. T. M., Sanmartín, A., de la Haba-Rodríguez, J., Denaro, D. M., & López, A. S. (2026) · Atención Primaria · doi:10.1016/j.aprim.2026.103518
LI, J., He, Y., Wu, Y., Tian, H., Zhou, Y., & Xiao, H. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.06.036
Acute Pericarditis After Targeted Kinase Inhibitor Therapy in Acute Leukemia
Fernández, M. P., & Carranco, A. R. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.108897
Ogieuhi, I. J., Chidera Stanley Anthony, M., Ajekiigbe, V. O., Ajao, F. A., Iyawe, E. P., Adegbesan, C. A., Adeshina, G. A., Moradeyo, A. A., Akingbola, A., & Ogunniyi, K. E. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10913-6
Sisca, L., Polito, M. G., Travisani, A., Zannino, F., Iuliani, M., Tonini, G., & Pantano, F. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18070792
Ma, S., Li, L., Chen, Y., & Zhao, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1831639
Bulsuhi, A. M. Y. A., Shehada, W., Suliman, S., Shah, J. Z., Kaddoura, R., Singh, K., Ali, N., Jama, A., JOHN, A., Babu, G. D. J., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10232618/v1
Postoperative Complications and Long-Term Cardiovascular Risk After Gastrectomy for Gastric Cancer
Hurh, K., Kwon, J., Park, J.-H., Kim, H. C., Rhee, H., Shim, J., Sa, J. K., Jung, Y., & Kim, E. (2026) · Annals of Surgical Oncology · doi:10.1245/s10434-026-20186-2
Metadata
- Authors
- Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., Patel, A., DeCara, J., Mitchell, J., Harrison, E., Moslehi, J., Witteles, R., Calabro, M. G., Orecchia, R., de Azambuja, E., Zamorano, J. L., Krone, R., Iakobishvili, Z., Carver, J., Armenian, S., Ky, B., Cardinale, D., Cipolla, C. M., Dent, S., & Jordan, K.
- Affiliations
- University of Milan (IT)
- Washington University Medical Center (US)
- University of South Florida (US)
- Lahey Hospital and Medical Center (US)
- Georgetown University (US)
- University of Minnesota (US)
- Mayo Clinic (US)
- University of Kansas Medical Center (US)
- Royal Brompton Hospital (GB)
- Centre Hospitalier Universitaire de Liège (BE)
- University of Chicago (US)
- Vanderbilt University (US)
- Stanford Medicine (US)
- European Institute of Oncology (IT)
- Hospital Universitario Ramón y Cajal (ES)
- Washington University in St. Louis (US)
- Tel Aviv University (IL)
- Hospital of the University of Pennsylvania (US)
- City Of Hope National Medical Center (US)
- University of Pennsylvania (US)
- Duke University (US)
- Heidelberg University (DE)
- ORCID
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 31
- Issue
- 2
- Pages
- 171-190
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC8019325
- OpenAlex
- W2999536665
- Cited by
- 1,031
- References
- 221
- Citations by year
- 2026: 108 · 2025: 152 · 2024: 168 · 2023: 189 · 2022: 188 · 2021: 143 · 2020: 83
- FWCI
- 93.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- HF
- Genentech
- Amgen
- Servier
- Pfizer
- Bristol-Myers Squibb
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- cardio-oncology, cardiotoxicity, cancer therapy, heart failure, cardiovascular screening, cardiovascular monitoring, novel cancer therapies, cardiovascular disease in cancer patients
- MeSH terms
- Antineoplastic Agents, Heart Diseases, Humans, Medical Oncology, Neoplasms, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
